Free T4 in Athletes: What Your Thyroxine Level Actually Means
Table of Contents
Introduction
In my clinical experience, TSH and free T4 are often interpreted together when screening for thyroid disease, but in athletes the picture is not always straightforward. I sometimes see low-normal free T4 together with low or low-normal TSH, especially in endurance athletes, weight-class athletes, and athletes who have been dieting, cutting weight, or training hard with insufficient energy intake.
Importantly, this pattern is not specific to athletes per se. It is more closely related to the balance between energy intake, energy expenditure, recent weight loss, and overall energy availability. Athletes are simply one group in whom it is commonly encountered because high training loads, strict competition diets, and weight-class requirements can create prolonged or repeated periods of low energy availability.
This pattern should not automatically be labelled as thyroid disease. In the right context, it may reflect adaptive downregulation of the hypothalamic-pituitary-thyroid axis rather than primary thyroid failure. At the same time, it should not be dismissed without clinical assessment, because genuinely low free T4, especially with an inappropriately low or normal TSH, can also suggest central thyroid dysfunction or other illness.
What Free T4 in Athletes Actually Measures
The thyroid gland produces two main hormones: thyroxine (T4) and triiodothyronine (T3). T3 is generally considered the more metabolically active hormone, while T4 functions largely as its circulating precursor and can be converted to T3 in peripheral tissues through a process called deiodination. Under conditions of low energy availability, this conversion may be impaired, contributing to reduced T3 despite adequate or elevated T4. [2]
Most T4 in the blood is bound to transport proteins, primarily thyroxine-binding globulin (TBG). Only the small unbound fraction — free T4 (fT4) — is biologically available. When clinicians order a thyroid panel, free T4 reflects the unbound circulating fraction of T4, but it does not by itself define tissue-level thyroid hormone action or T4-to-T3 conversion status. [7]
One large Olympic athlete cohort used a laboratory reference range for fT4 of 12–22 pmol/L — a range established by the Roche Cobas immunoassay system used in that study. [1] Exact reference ranges vary by assay and laboratory.
Thyroid-stimulating hormone (TSH) is released by the pituitary and acts as the main signal regulating thyroid hormone output through a negative feedback loop: when free T4 falls, TSH rises to stimulate more thyroid production; when free T4 is sufficient, TSH is suppressed. This negative feedback loop is the basis of standard thyroid screening using TSH and free T4 [7] — but in athletes, training status and energy availability may complicate interpretation of these baseline values [4].
In my clinical practice, the most familiar thyroid pattern is low free T4 with elevated TSH. When I see that combination, I start thinking about primary hypothyroidism. In that situation, I often check TPO antibodies to assess whether autoimmune thyroiditis could be the underlying cause.
However, I try not to make long-term conclusions from a single borderline result unless the clinical picture is clear. If the patient is stable and the abnormality is mild, I often repeat the thyroid tests after a short interval to see whether the pattern persists or whether it was a temporary fluctuation.
At the other end of the spectrum, high free T4 with suppressed TSH makes me think about thyrotoxicosis or hyperthyroidism. If inflammatory markers are elevated, thyroiditis may also be part of the differential diagnosis, depending on the symptoms and clinical context. I approach this pattern carefully because the underlying cause matters: Graves’ disease, toxic nodular disease, thyroiditis, medication effects, and rarer causes are treated differently.
This is why I am cautious with isolated free T4 results in athletes. A thyroid panel can point us in the right direction, but it does not replace clinical reasoning. The same free T4 value can mean different things depending on whether the athlete is well-fueled and recovering normally, in a prolonged energy deficit, acutely ill, using supplements, or developing genuine thyroid disease.
How Endurance Training Is Associated with Lower Free T4 in Athletes
Here is the central challenge for interpreting free T4 in athletes: in one large observational athlete cohort, endurance athletes showed lower thyroid hormone concentrations, including fT4, compared with other athlete groups — after exclusion of athletes taking thyroid hormones, affected by thyroiditis, or presenting TSH out of range.
In a study of 1342 Olympic and international-level athletes (mean age 25.6 ± 5.1 years) across power, skill, endurance, and mixed disciplines, endurance athletes presented the lowest TSH (p < 0.0001), fT3 (p = 0.007), and fT4 (p < 0.0001) in comparison to the remaining ones. [1] The study excluded athletes taking thyroid hormones, affected by thyroiditis, or presenting TSH out of ranges — meaning all included athletes had TSH values within the study laboratory’s reference range at the time of assessment.
This cross-sectional observation should not be interpreted as proof that endurance training causally lowers thyroid hormones. What it does show is that, in this cohort, endurance athletes had lower mean TSH, fT3, and fT4 values than athletes in other discipline groups.
One plausible mechanism, particularly in athletes with inadequate fueling, is low energy availability. Under low energy availability (LEA) — the primary driver of Relative Energy Deficiency in Sport (RED-S) — studies in previously untrained regularly menstruating females showed LEA induces a nonlinear reduction of T3 and free T3 levels, which is associated with decreased metabolism and energy expenditure in states of reduced energy availability. [2] The impact on free T4 in athletes itself is less consistent: some studies show an increase in T4, suggesting a potential mechanism related to decreased conversion of T4 to T3, which is the active thyroid hormone; other studies identified a decrease in T4 levels or did not detect a difference. [2]
For strength athletes, the picture appears more stable. In one small 1-year longitudinal study of 11 elite weightlifters, no systematic changes were found in the concentrations of serum thyrotropin (TSH), thyroxine (T4), free thyroxine (FT4), tri-iodothyronine (T3) and thyroxine binding globulin (TBG) over the overall training period. [3] This finding should not be generalized broadly — the sample was small and specific to weightlifters — but it adds to the picture that sport type and training characteristics may be relevant when interpreting thyroid panels in athletes. [3]
In my clinical practice, I try not to think of this pattern as specific to athletes. A similar picture can sometimes be seen in anyone with prolonged low energy availability, including athletes who are under-fueled, weight-class athletes cutting weight, or non-athletes who are dieting aggressively.
When energy intake is low relative to energy expenditure, the body may shift toward a more energy-conserving state. In that context, TSH and free T4 can sometimes appear low or low-normal, and the symptom pattern may resemble what we see in endurance athletes with inadequate fueling: fatigue, poor recovery, cold intolerance, sleep disturbance, and reduced performance or training tolerance.
That said, this thyroid pattern is not diagnostic of low energy availability by itself. Low free T4 with an inappropriately low or normal TSH can also raise concern for central thyroid dysfunction, non-thyroidal illness, medication effects, or other systemic causes. For that reason, I interpret these results alongside the full clinical picture.
Free T4 in Athletes vs. Overtraining: The Diagnostic Overlap Problem
The clinical challenge that makes free T4 in athletes particularly difficult to interpret is that the symptoms of true hypothyroidism closely mirror those of overtraining syndrome. Symptoms of hypothyroidism, including depression, fatigue, and impaired sleep, are similar to those reported in overtraining. [4]
This creates a genuine diagnostic challenge. An athlete presents with unexplained fatigue, declining performance, and mood disturbances. Blood work shows TSH in the upper-normal range and free T4 in athletes sitting in the lower-normal range. Is this hypothyroidism requiring levothyroxine? Or is this a catabolic, energy-deficient training state that may improve with reduced load and improved nutrition?
A 2019 review specifically examining this question concluded that to date, no association has been identified between training state and hypothyroidism. [4] The same review notes that thyroid-stimulating hormone and free T4 are recommended to screen for thyroid disease, but athletes may have hypothalamic-pituitary dysfunction that may complicate interpretation of basal thyroid-stimulating hormone and free T4. [4]
For a deeper understanding of how training stress drives hormonal dysregulation beyond the thyroid, the articles on cortisol and overtraining and the T:C ratio in overtraining cover the adrenal and androgenic side of this picture in detail.
The critical implication for free T4 in athletes: a low-normal fT4 value should not be interpreted as thyroid disease without the broader clinical and biochemical context.
I would be careful not to describe this thyroid pattern as a direct consequence of overtraining itself. In many athletes, thyroid-axis changes appear more closely related to low energy availability or negative energy balance than to high training volume alone.
Clinically, these factors often overlap. An athlete who is training heavily may also be under-fueled, losing weight, sleeping poorly, and recovering poorly. This can create a symptom pattern that resembles overtraining syndrome, RED-S, or both. However, overtraining syndrome and low energy availability are not identical conditions, and they should not be used interchangeably.
From a thyroid perspective, the key issue is often the mismatch between energy intake and energy expenditure. Heavy training can contribute to that mismatch, but the thyroid findings should be interpreted in the broader context of fueling, recovery, illness, medications, symptoms, and repeat laboratory results — not as a simple direct effect of training load alone.
When Low Free T4 in Athletes Becomes Clinically Relevant: The RED-S Connection
RED-S/LEA is an important context in which thyroid markers require careful interpretation in athletes, particularly because much of the evidence comes from female energy-deprivation and female endurance athlete studies.
Short-term energy deprivation exercise studies, including previously untrained regularly menstruating females, showed that LEA induces a nonlinear reduction of T3 and free T3 levels, which is associated with decreased metabolism and energy expenditure in states of reduced energy availability, and an increase of reverse T3 levels (the inactive form of thyroid hormone). [2] Regarding free T4 in athletes specifically, more complex findings have been observed: an increase of T4 has been described, suggesting a potential mechanism related to decreased conversion of T4 to T3, which is the active thyroid hormone. Other studies either identified a decrease in T4 levels or did not detect a difference. [2]
What this pattern tells the clinician evaluating free T4 in athletes: in an energy-deficient athlete, variable fT4 in the presence of low T3 and elevated reverse T3 may reflect impaired T4-to-T3 conversion rather than adequate thyroid status. These T3/reverse T3 changes are not directly assessed by a TSH/fT4-only panel. [2]
A 2024 review published in Endocrine Reviews describes T3/free T3 reductions as more consistent in LEA-related states than T4/free T4 changes, which are variable. [2] In athletes with suspected LEA/RED-S, clinicians may therefore consider markers beyond TSH and fT4; this should be individualized based on clinical presentation rather than applied as a universal standard.
RED-S drives a cascade of consequences beyond the thyroid. The articles on calcium in athletes and sleep for athletes cover two of the most commonly overlooked downstream effects of chronic energy deficiency.
For many weight-class athletes, low energy availability and RED-S can become particularly difficult because they directly conflict with the athlete’s goals. The athlete may be trying to reduce body weight for competition, but the body responds by conserving energy, reducing training tolerance, and making further weight loss harder.
I also recognize this from my own background in weight-class sports. When weight loss is pushed too aggressively, the body can feel as if it has shifted into an energy-saving mode: performance drops, recovery becomes slower, fatigue increases, and continued weight reduction becomes more difficult. In practice, this often reflects a mismatch between the athlete’s target weight, the speed of weight loss, total energy intake, and training demands.
This is not simply a matter of willpower. Sometimes the problem is that the weight cut is too rapid or too ambitious. In other cases, the chosen weight class may not be physiologically suitable for that athlete, at least not without unacceptable effects on health, recovery, or performance.
Subclinical Hypothyroidism and Free T4 in Athletes: To Treat or Not?
Subclinical hypothyroidism (sHT) is defined as elevated TSH with preserved (normal) free T4 in athletes. It can occur in athletes as in the general population, but its performance implications remain uncertain.
A 2025 narrative review specifically examining levothyroxine (LT4) therapy in subclinical hypothyroidism with a focus on its implications for athletic performance concluded that the most consistent findings relate to cardiac physiology: LT4 therapy reverses diastolic dysfunction, reduces systemic vascular resistance, and enhances cardiopulmonary reserve, suggesting that functional cardiac abnormalities in sHT are largely reversible. [5] However, the same review found that overall, LT4 therapy in sHT shows promise in improving selected physiological parameters, yet evidence for meaningful enhancement of overall exercise capacity or athletic performance remains weak. [5]
A 2019 review reported no scientific evidence at that time that thyroid medication has the potential to enhance performance. [4] More recent review literature continues to find the evidence base weak. [5] Thyroid hormones are not currently prohibited by WADA; a 2022 regulatory review discussing thyroid hormone abuse in elite sport concluded that, based on available evidence, prohibition was neither justified nor feasible. [6]
For clinicians, the message regarding free T4 in athletes is clear: available review evidence does not support thyroid medication solely for performance enhancement or for low-normal fT4 in the absence of confirmed thyroid disease.
In my clinical experience, patients with persistent fatigue often understandably look for a clear biological explanation for their symptoms. This is human and clinically important: fatigue is real, distressing, and often functionally limiting. However, the explanation is not always found in a single borderline laboratory abnormality.
Over the years, I have seen different labels become popular explanations for unexplained fatigue. At one point, subclinical hypothyroidism was often discussed as a possible hidden cause, even in situations where many clinicians would not consider the thyroid results sufficient to explain the symptoms. In other periods, chronic borreliosis was sometimes suspected on the basis of mildly positive or nonspecific antibody findings. More recently, low ferritin has often been discussed in a similar way, sometimes as if it alone could explain a broad fatigue syndrome.
The problem is not that thyroid disease, iron deficiency, or infections are unimportant. They absolutely can matter, and they should be assessed properly when the clinical picture supports it. The problem is over-attribution: taking a borderline or nonspecific result and using it as the main explanation for complex fatigue without enough supporting evidence.
For athletes, this matters because fatigue should be taken seriously, but it should not be forced into a thyroid diagnosis just because free T4 or TSH sits near one end of the reference range. The goal is not to dismiss the symptoms. The goal is to interpret the laboratory result honestly and avoid turning every borderline abnormality into a disease label.
Conclusion: Free T4 in Athletes Is a Starting Point, Not a Diagnosis
Free T4 in athletes should never be interpreted in isolation. A low-normal value may reflect genuine thyroid disease, but it may also appear in the context of low energy availability, recent weight loss, aggressive dieting, heavy training, illness, or poor recovery. This is why I do not treat free T4 as a standalone verdict. I interpret it together with TSH, symptoms, training load, nutrition, weight history, recovery status, medication and supplement use, and repeat laboratory results when needed.
The key clinical point is that the same laboratory pattern can mean different things in different athletes. Low free T4 with elevated TSH points toward primary hypothyroidism and deserves appropriate evaluation. Low or low-normal free T4 with low or low-normal TSH, especially in an under-fueled endurance or weight-class athlete, may suggest a broader energy-conservation pattern rather than primary thyroid failure. At the same time, it should not be dismissed automatically, because central thyroid dysfunction, non-thyroidal illness, medication effects, and other systemic causes must remain part of the differential diagnosis.
For athletes, the practical message is simple: fatigue is real, but every borderline thyroid result should not become a disease label. Before assuming that free T4 is the cause of poor performance, the broader picture must be reviewed carefully. Energy availability, sleep, recovery, training stress, iron status, mood, illness, and true thyroid disease all deserve consideration. Free T4 is useful, but only when it is interpreted as part of the full clinical story.
References
[1] https://doi.org/10.3390/biomedicines12071530
[2] https://academic.oup.com/edrv/article/45/5/676/7629683
[3] https://pubmed.ncbi.nlm.nih.gov/8114173/
[4] https://pubmed.ncbi.nlm.nih.gov/31834179/
[5] https://pubmed.ncbi.nlm.nih.gov/41329972/
